126 related articles for article (PubMed ID: 9366673)
41. Immunohistochemical evidence of heterogeneity in macular corneal dystrophy.
Yang CJ; SundarRaj N; Thonar EJ; Klintworth GK
Am J Ophthalmol; 1988 Jul; 106(1):65-71. PubMed ID: 3293458
[TBL] [Abstract][Full Text] [Related]
42. Novel CHST6 nonsense and missense mutations responsible for macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Shalaby O; Wilkins S; Poopalasundaram S; Cheetham M; Tuft SJ; Hardcastle AJ; Bhattacharya SS; Ebenezer ND
Am J Ophthalmol; 2005 Jan; 139(1):192-3. PubMed ID: 15652851
[TBL] [Abstract][Full Text] [Related]
43. Novel mutations in the CHST6 gene causing macular corneal dystrophy.
Abbruzzese C; Kuhn U; Molina F; Rama P; De Luca M
Clin Genet; 2004 Feb; 65(2):120-5. PubMed ID: 14984470
[TBL] [Abstract][Full Text] [Related]
44. Sulfation of endothelial mucin by corneal keratan N-acetylglucosamine 6-O-sulfotransferase (GST-4beta).
Bartes A; Bhakta S; Hemmerich S
Biochem Biophys Res Commun; 2001 Apr; 282(4):928-33. PubMed ID: 11352640
[TBL] [Abstract][Full Text] [Related]
45. Corneal alpha-galactosidase deficiency in macular corneal dystrophy.
Bruner WE; Dejak TR; Grossniklaus HE; Stark WJ; Young E
Ophthalmic Paediatr Genet; 1985 Apr; 5(3):179-83. PubMed ID: 2999674
[TBL] [Abstract][Full Text] [Related]
46. Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland.
Liu NP; Dew-Knight S; Rayner M; Jonasson F; Akama TO; Fukuda MN; Bao W; Gilbert JR; Vance JM; Klintworth GK
Mol Vis; 2000 Dec; 6():261-4. PubMed ID: 11139648
[TBL] [Abstract][Full Text] [Related]
47. Novel mutations in the CHST6 gene associated with macular corneal dystrophy in southern India.
Warren JF; Aldave AJ; Srinivasan M; Thonar EJ; Kumar AB; Cevallos V; Whitcher JP; Margolis TP
Arch Ophthalmol; 2003 Nov; 121(11):1608-12. PubMed ID: 14609920
[TBL] [Abstract][Full Text] [Related]
48. Purification of chondroitin 6-sulfotransferase secreted from cultured chick embryo chondrocytes.
Habuchi O; Matsui Y; Kotoya Y; Aoyama Y; Yasuda Y; Noda M
J Biol Chem; 1993 Oct; 268(29):21968-74. PubMed ID: 8408053
[TBL] [Abstract][Full Text] [Related]
49. Genetic analysis of
Yaylacioglu Tuncay F; Kayman Kurekci G; Guntekin Ergun S; Pasaoglu OT; Akata RF; Dincer PR
Mol Vis; 2016; 22():1267-1279. PubMed ID: 27829782
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody.
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO
Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360
[TBL] [Abstract][Full Text] [Related]
51. Research into the pathogenesis of macular corneal dystrophy.
Klintworth GK
Trans Ophthalmol Soc U K (1962); 1980 Apr; 100(Pt 1):186-94. PubMed ID: 6973846
[TBL] [Abstract][Full Text] [Related]
52. Molecular genetic study of Egyptian patients with macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Shalaby O; Bhattacharya SS
Br J Ophthalmol; 2010 Feb; 94(2):250-5. PubMed ID: 19734134
[TBL] [Abstract][Full Text] [Related]
53. Macular corneal dystrophy type II: multiple studies on a cornea with low levels of sulphated keratan sulphate.
Quantock AJ; Fullwood NJ; Thonar EJ; Waltman SR; Capel MS; Ito M; Verity SM; Schanzlin DJ
Eye (Lond); 1997; 11 ( Pt 1)():57-67. PubMed ID: 9246278
[TBL] [Abstract][Full Text] [Related]
54. Sequencing of the CHST6 gene in Czech macular corneal dystrophy patients supports the evidence of a founder mutation.
Liskova P; Veraitch B; Jirsova K; Filipec M; Neuwirth A; Ebenezer ND; Hysi PG; Hardcastle AJ; Tuft SJ; Bhattacharya SS
Br J Ophthalmol; 2008 Feb; 92(2):265-7. PubMed ID: 17962390
[TBL] [Abstract][Full Text] [Related]
55. Mutation analysis of the carbohydrate sulfotransferase gene in Vietnamese with macular corneal dystrophy.
Ha NT; Chau HM; Cung le X; Thanh TK; Fujiki K; Murakami A; Hiratsuka Y; Kanai A
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3310-6. PubMed ID: 12882775
[TBL] [Abstract][Full Text] [Related]
56. Protamine increases the affinity of 3'-phosphoadenosine 5'-phosphosulfate toward a sulfotransferase from chicken embryo epiphyseal cartilage.
Salac ML; Santos JA; Mourão PA
Biochim Biophys Acta; 1986 Oct; 883(3):605-9. PubMed ID: 3092873
[TBL] [Abstract][Full Text] [Related]
57. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients.
Jonasson F; Oshima E; Thonar EJ; Smith CF; Johannsson JH; Klintworth GK
Ophthalmology; 1996 Jul; 103(7):1111-7. PubMed ID: 8684802
[TBL] [Abstract][Full Text] [Related]
58. Different mutations in carbohydrate sulfotransferase 6 (CHST6) gene cause macular corneal dystrophy types I and II in a single sibship.
Liu NP; Bao W; Smith CF; Vance JM; Klintworth GK
Am J Ophthalmol; 2005 Jun; 139(6):1118-20. PubMed ID: 15953452
[TBL] [Abstract][Full Text] [Related]
59. Regulation of serum glycosaminoglycan sulfotransferase activities: inhibition by sulfated glycosaminoglycans and activation by polyamines and basic peptides including a polylysine-containing segment of the c-Ki-ras 2 protein.
Sugahara K; Nakamura M; Nagisa J; Masuda M; Nunokawa Y; Fujii N; Yamashina I
J Biochem; 1989 Nov; 106(5):910-9. PubMed ID: 2515192
[TBL] [Abstract][Full Text] [Related]
60. Elevated chondroitin 6-sulfotransferase activity in fetal bovine serum.
Sugahara K; Shibamoto S; Yamashina I
FEBS Lett; 1985 Apr; 183(1):43-6. PubMed ID: 3856526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
